Catalyst Wire Dossier Catalyst Wire Dossier

Estradiol vaginal cream 0.01%

estradiol vaginal cream 0.01% · Actavis Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Estradiol vaginal cream 0.01%, covering 2019-12-26 to 2019-12-26. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis [Phase 3]

See pricing